Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa [4]

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 4, 2007, Pages 452-

  Ikenouchi Sugita, Atsuko ^a   Yoshimura, Reiji ^a   Hori, Hikaru ^a   Ueda, Nobuhisa ^a   Nakamura, Jun ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE;

BULIMIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MONITORING; HAMILTON SCALE; HUMAN; INFORMED CONSENT; LETTER; RATING SCALE; SCORING SYSTEM;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BULIMIA NERVOSA; DEPRESSION; DRUG MONITORING; FEMALE; FLUVOXAMINE; HUMANS; PSYCHIATRIC STATUS RATING SCALES;

EID: 34347393561     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01682.x     Document Type: Letter

References (4)

1. Gerstenberg G, Aoshima T, Fukasawa T et al. Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients. Psychopharmacology 2003 167 : 443 448.
2. Henderson M, Freeman CPL. A self-rating scale for bulimia: The BITE. Br. J. Psychiatry 1987 150 : 18 24.
3. Yoshimura R, Ueda N, Nakamura J, Eto S, Matsushita M. Interaction between fluvoxamine and cotinine or caffeine. Neuropsychobiology 2002 45 : 32 35.
4. Ueda N, Yoshimura R, Nakamura J. Fluvoxamine improves some depressive symptoms by influencing noradrenergic neurons. Psychiatry Res. (in press).